Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital — Philadelphia, Pennsylvania

Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Retinitis Pigmentosa, Leber Congenital Amaurosis.

Sponsors: Ocugen.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital?

Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital conducted?

Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital has 1 clinical trials on record, with 1 currently active. Their work covers Retinitis Pigmentosa, Leber Congenital Amaurosis.

Is Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital accredited by Crixeo Health?

Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ocugen Site 8 - Mid Atlantic Retina - Wills Eye Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.